Serum procalcitonin: Early detection of neonatal bacteremia and septicemia in a tertiary healthcare facility

North American Journal of Medical Sciences

Volumn 3, Issue 3, 2011, Pages 157-160

  Nnanna, Ibeh Isaiah ^a   Ehis, Osifo John ^a   Sidiquo, Iyere Itoya ^a   Nnanna, Ibeh Georgina ^a   Adekunle, Olowe ^b  

^a UNIVERSITY OF BENIN   (Nigeria)

^b University of Technology   (Nigeria)

Author keywords

Bacteremia; Calcitonin; Neonates; Procalcitonin; Septicemia

Indexed keywords

PROCALCITONIN;

ARTICLE; BACTEREMIA; CALCITONIN BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FEVER; HEALTH CARE FACILITY; HUMAN; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; NEWBORN; NEWBORN INTENSIVE CARE; NEWBORN SEPSIS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; TERTIARY HEALTH CARE;

EID: 79953234460     PISSN: None     EISSN: 19472714     Source Type: Journal    
DOI: 10.4297/najms.2011.3157     Document Type: Article

References (21)

1. Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med 1999; 160: 976-981.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive care (EPIC) study. EPIC International Advisory Committee. JAMA 1995; 274: 639-644.
3. Gastmeier P, Sohr D, Geffers C, Behnke M, Ruden H. Risk factors for death due to nosocomial infection in intensive care unit patients: Findings from the krankenhaus infections surveillance system. Infect Control Hosp Epidemiol 2007; 28:466-472.
4. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 2003; 115:529-535.
5. Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotic use in ICU patients: A one-year prospective surveillance. J Antimicrob Chemother 1997; 39:527-535.
6. Christ-Crain M, Muller B. Procalcitonin in bacterial infections - hype, hope, more or less? Swiss Med Wkly 2005; 135:451-460.
7. Jensen JU, Heslet L, Jensen TH, Espersen K, Steffensen P, Tvede M. Procalcitonin increase in early identification of critically ill patients at high risk of mortality. Crit Care Med 2006; 34:2596-2602.
8. Rau B, Steinbach G, Gansauge F, Mayer JM, Grunert A, Beger HG. The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 1997; 41:832-840.
9. Rau BM, Frigerio I, Buchler MW, et al. Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: A prospective, international multicenter study. Arch Surg 2007; 142:134-142.
10. Amour J, Birenbaum A, Langeron O, et al. Influence of renal dysfunction on the accuracy of procalcitonin for the diagnosis of postoperative infection after vascular surgery. Crit Care Med 2008; 36:1147-1154.
11. Siassi M., Riese J., Steffensen R., et al. Mannan-binding lectin and procalcitonin measurement for prediction of postoperative infection. Crit Care 2005; 9:R483-489.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992; 20:864-874.
13. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind bronchoalveolar lavage fluid. Am Rev Respir Dis 1991; 143:1121-1129.
14. Luyt CE, Combes A, Reynaud C, et al. Usefulness of procalcitonin for the diagnosis of ventilator-associated pneumonia. Intensive Care Med 2008; 34:1434-40.
15. Clech C, Fosse JP, Karoubi P, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006; 34:102-107.
16. Charles PE, Ladoire S, Snauwaert A, et al. Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients. BMC Infect Dis 2008; 8:163.
17. Ramirez P, Garcia MA, Ferrer M, et al. Sequential measurements of procalcitonin levels in diagnosing ventilator-associated pneumonia. Eur Respir J 2008; 31: 356-362.
18. Charles PE, Dalle F, Aho S., et al.Serum procalcitonin measurement contribution to the early diagnosis of candidemia in critically ill patients. Intensive Care Med 2006; 32:1577-1583.
19. Charles PE, Ladoire S, Aho S, et al. Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either gram negative or gram positive bacteria. BMC Infect Dis 2008; 8: 38.
20. Schurink CA, Van Nieuwenhoven CA, Jacobs JA, et al. Clinical pulmonary infection score for ventilator-associated pneumonia: accuracy and inter observer variability. Intensive Care Med 2004; 30: 217-224.
21. Luyt CE, Chastre J, Fagon J Y. Value of the clinical pulmonary infection score for the identification and management of ventilator-associated pneumonia. Intensive Care Med 2004; 30:735-738.